Literature DB >> 17396990

Herpes simplex virus type 2 and HIV-1: the dialogue between the 2 organisms continues.

Lawrence Corey1.   

Abstract

Entities:  

Mesh：

Year:  2007        PMID： 17396990     DOI： 10.1086/513570

Source DB:  PubMed          Journal:  J Infect Dis        ISSN： 0022-1899            Impact factor:   5.226


× No keyword cloud information.
  14 in total

1.  Zinc acetate/carrageenan gels exhibit potent activity in vivo against high-dose herpes simplex virus 2 vaginal and rectal challenge.

Authors:  José A Fernández-Romero; Ciby J Abraham; Aixa Rodriguez; Larisa Kizima; Ninochka Jean-Pierre; Radhika Menon; Othell Begay; Samantha Seidor; Brian E Ford; Pedro I Gil; Jennifer Peters; David Katz; Melissa Robbiani; Thomas M Zydowsky
Journal:  Antimicrob Agents Chemother       Date:  2011-11-07       Impact factor: 5.191

2.  Use of injectable hormonal contraception and women's risk of herpes simplex virus type 2 acquisition: a prospective study of couples in Rakai, Uganda.

Authors:  Mary K Grabowski; Ronald H Gray; Fred Makumbi; Joseph Kagaayi; Andrew D Redd; Godfrey Kigozi; Steven J Reynolds; Fred Nalugoda; Tom Lutalo; Maria J Wawer; David Serwadda; Thomas C Quinn; Aaron A R Tobian
Journal:  Lancet Glob Health       Date:  2015-06-17       Impact factor: 26.763

3.  A novel intravaginal ring to prevent HIV-1, HSV-2, HPV, and unintended pregnancy.

Authors:  Shweta R Ugaonkar; Asa Wesenberg; Jolanta Wilk; Samantha Seidor; Olga Mizenina; Larisa Kizima; Aixa Rodriguez; Shimin Zhang; Keith Levendosky; Jessica Kenney; Meropi Aravantinou; Nina Derby; Brooke Grasperge; Agegnehu Gettie; James Blanchard; Narender Kumar; Kevin Roberts; Melissa Robbiani; José A Fernández-Romero; Thomas M Zydowsky
Journal:  J Control Release       Date:  2015-06-17       Impact factor: 9.776

Review 4.  Protein and oligonucleotide delivery systems for vaginal microbicides against viral STIs.

Authors:  Jill M Steinbach
Journal:  Cell Mol Life Sci       Date:  2014-10-17       Impact factor: 9.261

5.  Mucosal innate and adaptive immune responses against herpes simplex virus type 2 in a humanized mouse model.

Authors:  Amanda Kwant-Mitchell; Ali A Ashkar; Kenneth L Rosenthal
Journal:  J Virol       Date:  2009-08-05       Impact factor: 5.103

Review 6.  Vertical transmission of genital herpes: prevention and treatment options.

Authors:  Cheryl A Jones
Journal:  Drugs       Date:  2009       Impact factor: 9.546

Review 7.  [Genital herpes and HSV transmission in HIV patients].

Authors:  H F Rabenau; H W Doerr
Journal:  Hautarzt       Date:  2008-01       Impact factor: 0.751

8.  In Vitro Exposure to PC-1005 and Cervicovaginal Lavage Fluid from Women Vaginally Administered PC-1005 Inhibits HIV-1 and HSV-2 Infection in Human Cervical Mucosa.

Authors:  Guillermo Villegas; Giulia Calenda; Shimin Zhang; Olga Mizenina; Kyle Kleinbeck; Michael L Cooney; Craig J Hoesley; George W Creasy; Barbara Friedland; José A Fernández-Romero; Thomas M Zydowsky; Natalia Teleshova
Journal:  Antimicrob Agents Chemother       Date:  2016-08-22       Impact factor: 5.191

9.  A macaque model to study vaginal HSV-2/immunodeficiency virus co-infection and the impact of HSV-2 on microbicide efficacy.

Authors:  Federica Crostarosa; Meropi Aravantinou; Onome J Akpogheneta; Edith Jasny; Andrew Shaw; Jessica Kenney; Michael Piatak; Jeffrey D Lifson; Aaron Teitelbaum; Lieyu Hu; Anne Chudolij; Thomas M Zydowsky; James Blanchard; Agegnehu Gettie; Melissa Robbiani
Journal:  PLoS One       Date:  2009-11-30       Impact factor: 3.240

10.  In captive rhesus macaques, cervicovaginal inflammation is common but not associated with the stable polymicrobial microbiome.

Authors:  Gregory Spear; Kristina Rothaeulser; Linda Fritts; Patrick M Gillevet; Christopher J Miller
Journal:  PLoS One       Date:  2012-12-28       Impact factor: 3.240
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.